TY - JOUR T1 - Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 122 LP - 122 DO - 10.1136/bjo.2004.050575 VL - 89 IS - 1 AU - J B Jonas AU - I Kreissig AU - R F Degenring AU - B A Kamppeter Y1 - 2005/01/01 UR - http://bjo.bmj.com/content/89/1/122.1.abstract N2 - Recent studies have suggested that intravitreal triamcinolone acetonide may be a treatment option for diffuse diabetic macular oedema.1 Since the duration of the effect of an intravitreal application of triamcinolone acetonide lasts between 4 weeks and up to 9 months,2,3 the purpose of this study was to evaluate the effect of a repeated intravitreal injection of triamcinolone acetonide. The clinical interventional case series study included four patients with diffuse diabetic macular oedema who consecutively received a second intravitreal injection of about 20 mg triamcinolone acetonide 7.6 (SD 3.9) … ER -